- Publications
- Influence
Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage publications.
- Naifi Calzada Gutiérrez, M F Víctor Castellanos, +15 authors Jesús San Miguel
- Leukemia
- 2007
Fluorescence in situ hybridization (FISH) has become a powerful technique for prognostic assessment in multiple myeloma (MM). However, the existence of associations between cytogenetic abnormalities… (More)
- Jesús F San Miguel, Juan José Lahuerta, +40 authors Joaquín Díaz-Mediavilla
- The hematology journal : the official journal of…
- 2000
INTRODUCTION
Renal function is one of the most important prognostic factors in multiple myeloma (MM). Patients with renal failure are generally excluded from high dose therapy even though they… (More)
- Antonio Salar, Eva Domingo-Doménech, +18 authors Carlos Montalbán
- The Lancet. Haematology
- 2014
BACKGROUND
No standard first-line systemic treatment for mucosa-associated lymphoid tissue (MALT) lymphoma is available. In a phase 2 study we aimed to assess the safety and activity of a… (More)
- Manuel Pérez-Encinas, Alfonso López Quintás, A Bendaña, M J Rabuñal, José Luis Bello
- Leukemia & lymphoma
- 1999
Serum levels of sICAM-1, sIL-2alphaR, and beta-2 microglobulin were measured in 63 patients with non-Hodgkin's lymphoma (NHL). The correlation between these serum markers as well as their… (More)
- Antonio Salar, Eva Domingo-Doménech, +18 authors Carlos Montalbán
- Blood
- 2017
To the editor:
Extranodal marginal zone B-cell lymphomas of mucosa-associated lymphoid tissue (MALT) present in most cases as localized disease and can be successfully treated with local therapies… (More)
- C Richard, Iñigo Romon, +11 authors A Zubizarreta
- Leukemia
- 1996
We report four patients with chronic myeloid leukemia (CML) that showed poor graft function after a non-T-depleted bone marrow transplantation (BMT) from an HLA-compatible sibling donor and who were… (More)
- Eva González-Barca, Alejandro Martín, +23 authors Andres Lopez
- 2018
- Aurelio López, María Victoria Mateos, +17 authors Javier de la Rubia
- 2015
- Eva González-Barca, Miguel Angel Canales, +16 authors Dolores Caballero
- Acta haematologica
- 2016
BACKGROUND/AIMS
Rituximab-cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) every 14 days seems to achieve better outcomes than R-CHOP every 21 days in diffuse large B-cell lymphoma… (More)